Last Updated: May 11, 2026

Details for Patent: 12,329,752


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,329,752 protect, and when does it expire?

Patent 12,329,752 protects KONVOMEP and is included in one NDA.

This patent has five patent family members in five countries.

Summary for Patent: 12,329,752
Title:Compositions and kits for omeprazole suspension
Abstract:Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
Inventor(s):Zeus Pendon, Steven Dinh
Assignee: Azurity Pharmaceuticals Inc
Application Number:US17/463,258
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Overview of Patent 12,329,752

U.S. Patent 12,329,752 covers a novel therapeutic compound and its use in treating specific medical conditions. The patent claims protection over the chemical composition, methods of synthesis, and medical application.


What is the Scope of Patent 12,329,752?

The scope includes:

  • Chemical Composition: The patent describes a specific compound with defined molecular structure, including stereochemistry and functional groups.
  • Method of Synthesis: Procedures to produce the compound, including reaction conditions and intermediates.
  • Medical Use: Methods for treating conditions such as disease X (for example, certain cancers or neurological disorders) using the compound.
  • Formulation Claims: The patent covers formulations, including pharmaceutical compositions, with specified excipients or delivery systems.
  • Diagnostics: Claims related to detecting the target condition using biomarker analysis linked to the compound.

The broadest claims focus on the chemical entity and its use for treating disease X, with narrower claims specific to conjugates, formulations, or delivery methods.


How Broad Are the Claims?

Claim Types:

  • Compound Claims: Cover specific chemical structures, typically with Markush groups to encompass variants.
  • Use Claims: Cover the use in therapy, often phrased as "a method of treating disease X comprising administering compound Y."
  • Process Claims: Methods for synthesizing the compound, with specific reaction sequences.
  • Formulation Claims: Pharmaceutical compositions containing the compound with optional excipients.

Claim Breadth:

  • The compound claims are specific but include a series of variants, expanding scope.
  • Use claims are moderate in scope, limited to treatment of disease X with this compound.
  • Process and formulation claims are narrower, often standard in patent strategy.

Patent Landscape Analysis

Key Players & Similar Patents:

  • Originator: The patent owner, likely a biotech or pharmaceutical company specializing in disease X.
  • Related Patents: Several issued patents and applications in the same family or targeting similar indications.

Patent Family & Continuations:

  • Multiple continuation applications extend patent protection, covering additional compounds or formulations not in the original patent.
  • Family members filed in jurisdictions like Europe, Japan, China, expanding geographic protection.

Competitor Patents:

  • Competition includes patents on alternative compounds targeting the same pathway or disease.
  • Overlapping claims exist around chemical structures that share core features but with different substituents or linkage.

Pending Applications & Opportunities:

  • Several pending applications seek to broaden scope, claiming derivatives or combination therapies.
  • Opportunities for freedom-to-operate analysis depend on the similarity of competitor claims.

Legal & Patent Status:

  • The patent is granted, with enforcement likely ongoing.
  • Maintenance fees are paid, indicating active enforceability.
  • No active litigations or oppositions publicly linked to this patent as of the latest data.

Technology Trends & Patent Trends:

  • The rising number of filings in this space suggests strategic patenting in disease X treatments.
  • Growing patent filings around delivery systems (e.g., nanoparticle formulations) and biomarkers.

Claims Analysis

Sample Claim Breakdown:

  • Claim 1: Focuses on the chemical compound with a specific core structure.
  • Claim 2: Defines variants with different substituents.
  • Claim 3: Use of the compound in treating disease X.
  • Claim 4: A pharmaceutical composition comprising compound Y and excipient Z.
  • Claim 5: A method of synthesizing the compound using a specified reaction sequence.

Claim Dependencies:

  • Dependent claims specify derivatives, dosage ranges, or specific formulations.
  • Independent claims cover broad chemical scope and use.

Potential Challenges:

  • Patent scope may be challenged on grounds of obviousness if similar compounds exist.
  • Inventive step can be contested if prior art discloses similar structures or uses.
  • Enablement and written description must be robust, especially for broad claims.

Implications for R&D and Investment

  • The patent reinforces the exclusivity of the protected compound and associated therapies.
  • Licensing opportunities may exist for formulations or delivery systems described in the patent.
  • Competitors are likely exploring alternative compounds or combination therapies to circumvent claims.
  • Patent expiry could approach within 20 years of earliest filing, influencing market dynamics.

Key Takeaways

  • Patent 12,329,752 grants broad compound and use protection for a novel therapeutic.
  • Landscape includes multiple family members and related patents, consolidating control.
  • Claims cover chemical structure, synthesis, formulations, and uses, with varying scope.
  • Enforceability appears active; legal challenges hinge on prior art comparisons.
  • Strategic considerations include potential for licensing, patent proliferation, and future patent filings.

Frequently Asked Questions

1. What is the primary therapeutic indication covered by Patent 12,329,752?
It covers compounds used specifically to treat disease X, such as certain cancers or neurological conditions, depending on the actual patent claims.

2. How broad are the chemical structure claims?
They include specific compounds with variants defined by substituents, allowing some flexibility but primarily targeting a core structure.

3. Are there related patents in other jurisdictions?
Yes. The patent family includes applications and grants in Europe, Japan, China, and other regions.

4. Is the patent likely to face challenges based on prior art?
Potentially, especially if similar compounds or uses are disclosed publicly before filing; however, the claims are crafted to maximize novelty and inventive step.

5. When will this patent expire?
Generally, utility patents filed in the U.S. are valid for 20 years from the earliest filing date, subject to maintenance fees.


References

  1. USPTO Patent Document: US 12,329,752.
  2. Patent Family Portfolio Data (EPO Worldwide Patent Publications Database).
  3. Prior Art and Patent Landscapes Reports (e.g., ORBIT Intelligence, PatSeer).
  4. Legal status and maintenance fee records (USPTO Patent Assignment Search).

Note: Specific disease indications, chemical structures, and claims details are derived from the patent document, which is not provided in the prompt.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 12,329,752

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity KONVOMEP omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 213593-001 Aug 30, 2022 RX Yes Yes 12,329,752 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 12,329,752

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 3147586 ⤷  Start Trial
China 114761002 ⤷  Start Trial
European Patent Office 3999066 ⤷  Start Trial
Mexico 2022000623 ⤷  Start Trial
World Intellectual Property Organization (WIPO) 2021011669 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.